Breathe Well Live Well
Conditions: Asthma; Moderate Asthma
Interventions: Drug: REGN3500; Drug: Placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi
Not yet recruiting – verified December 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Condition: Moderate Asthma
Intervention: Device: Bronchial Thermoplasty
Sponsor: Guangzhou Institute of Respiratory Disease
Recruiting – verified November 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Condition: Asthma
Intervention: Behavioral: Electronic sensor and OW education
Sponsor: Montefiore Medical Center
Not yet recruiting – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma?
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):791-3
Authors: Liccardi G, Salzillo A, Calzetta L, Ora J, Cazzola M, Matera MG, Rogliani P
PMID: 27393788 [PubMed – in process]
View full post on pubmed: asthma
|
HDM SLIT tablet can reduce risk of moderate or severe asthma exacerbation
News-Medical.net The addition of a house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablet to maintenance medications improved time to first moderate or severe asthma exacerbation during a period of inhaled corticosteroid (ICS) reduction among adults with … House dust mite immunotherapy in adults with allergic asthma |
View full post on asthma – Google News
Condition: Asthma
Intervention: Drug: MEDI9929 (AMG 157)
Sponsors: MedImmune LLC; Amgen
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium/Formoterol; Drug: Placebo
Sponsors: AstraZeneca; Menarini (Co-Funder)
Not yet recruiting – verified April 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Budesonide, formoterol regular therapy better for moderate asthma
Healio “Our results show that as-needed budesonide and formoterol is inferior to regular budesonide and formoterol plus as-needed terbutaline in preventing treatment failure and in maintaining asthma control,” Alberto Papi, MD, of the department of … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Biological: Benralizumab; Biological: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Pulmonary Disease, Chronic Obstructive; Overweight
Interventions: Dietary Supplement: Resveratrol; Dietary Supplement: Placebo
Sponsors: Maastricht University Medical Center; The Netherlands Asthma Foundation; DSM Nutritional Products, Inc.
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days